Importance of hyperlipidaemia and therapy in renal patients.
作者信息
Wanner C
机构信息
Department of Medicine, Division of Nephrology, University of Würzburg, Germany.
出版信息
Nephrol Dial Transplant. 2000;15 Suppl 5:92-6. doi: 10.1093/ndt/15.suppl_5.92.
PMID:11073280
Abstract
摘要
相似文献
1
Importance of hyperlipidaemia and therapy in renal patients.
Nephrol Dial Transplant. 2000;15 Suppl 5:92-6. doi: 10.1093/ndt/15.suppl_5.92.
2
Hyperlipidemia in atherosclerosis. Dietary and drug treatment.
Med Clin North Am. 1970 May;54(3):657-69.
3
[Hyperlipidemia complicated with hypertension].
Nihon Rinsho. 2001 Mar;59 Suppl 3:738-42.
4
Should hyperlipidaemia in dialysis patients be treated?
Nephrol Dial Transplant. 1997 Jan;12(1):19-21. doi: 10.1093/ndt/12.1.19.
5
Regression of computer estimated femoral atherosclerosis after pronounced serum lipid lowering in patients with asymptomatic hyperlipidaemia.
Lancet. 1982 Jun 5;1(8284):1311. doi: 10.1016/s0140-6736(82)92881-1.
6
Lipids and Renal Disease.
Methodist Debakey Cardiovasc J. 2019 Jan-Mar;15(1):88-89. doi: 10.14797/mdcj-15-1-88.
7
Atherosclerotic disease in non-insulin-dependent diabetes mellitus: role of abnormal lipids and the place for lipid-altering therapies.
Am Heart J. 1999 Nov;138(5 Pt 1):S406-12. doi: 10.1016/s0002-8703(99)70043-8.
8
Management of hyperlipidaemia. Why, when and how to treat.
Eur Heart J. 1997 Mar;18(3):371-5. doi: 10.1093/oxfordjournals.eurheartj.a015257.
9
[Hyperlipidemia in patients with ischemic heart disease].
Nihon Rinsho. 2001 Mar;59 Suppl 3:722-7.
10
[Lipid distress syndrome in atherosclerosis obliterans].
Vestn Ross Akad Med Nauk. 1999(9):28-31.
引用本文的文献
1
Cardiovascular risk is similar in patients with glomerulonephritis compared to other types of chronic kidney disease: a matched cohort study.
BMC Nephrol. 2017 Mar 20;18(1):95. doi: 10.1186/s12882-017-0511-z.
2
Serum lipid profiles, lipid ratios and Chronic Kidney Disease in a Chinese population.
Int J Environ Res Public Health. 2014 Jul 29;11(8):7622-35. doi: 10.3390/ijerph110807622.
3
Assessment of dyslipidemia in pre-dialysis patients in south-west Nigeria.
Niger Med J. 2014 May;55(3):214-9. doi: 10.4103/0300-1652.132043.
4
Effects of hemodialysis on serum lipids and phospholipids of end-stage renal failure patients.
Mol Cell Biochem. 2004 Oct;265(1-2):57-61. doi: 10.1023/b:mcbi.0000044315.74038.78.
Zotero 插件